Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FZ88B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,102
Award facts
- Contract value 100% obligated
- $25,102.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,102.15 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune and inflammatory conditions. This firm fixed-price delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive, non-set-aside award executed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performable at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters.
This delivery order falls under AmerisourceBergen's larger $999,999,999.00 DLA Troop Support Medical IDC (contract SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contracts supplying branded and generic medications, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's established position as a prime vendor reflects its capability to meet federal procurement requirements and support military healthcare logistics on a global scale.
Quick answers
Who was awarded contract SPE2DR26FZ88B?
SPE2DR26FZ88B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FZ88B worth?
The government has obligated $25,102 on SPE2DR26FZ88B.
Is contract SPE2DR26FZ88B an order under another contract?
Yes. SPE2DR26FZ88B is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ88B competed?
The extent of competition for SPE2DR26FZ88B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award